COMP <GO>
ACHC vs FTRE // RSI-14 & 200D SMA MOMENTUM
Acadia Healthcare Company Inc. (NASDAQ) VS. Fortrea Holdings Inc. (NASDAQ) • 15-METRIC TALLY: ACHC 8
— FTRE 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ACHC
LAST: $29.62 (-1.13%) • MKT CAP: $2.79B
rsi-technicals
50.9
LAST: $20.02 (-5.96%) • MKT CAP: $2.05B
rsi-technicals
46.4
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACHC VS. FTRE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACHC | FTRE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -24.80% | -35.00% | +10.20 | ACHC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -16.04% | -0.41% | -15.63 | FTRE | /fcf-yield <GO> |
| Operating Margin | -40.60% | -32.00% | -8.60 | FTRE | /operating-margins <GO> |
| Net Profit Margin | -33.30% | -36.30% | +3.00 | ACHC | /net-margins <GO> |
| Revenue Growth (YoY) | 5.00% | 1.00% | +4.00 | ACHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.45 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 3/9 | +2.00 | ACHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 50.9 | 46.4 | +4.50 | ACHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.99 | +0.08 | ACHC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 29.0x | -8.00 | ACHC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.79B | $2.05B | $734.8M | ACHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACHC REV | FTRE REV | ACHC GROSS % | FTRE GROSS % | ACHC FCF | FTRE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.31B | $2.72B | — | — | -$439.9M | -$9.1M |
| FY 2024 | $3.15B | $2.70B | — | — | -$560.7M | $141.5M |
| FY 2023 | $2.93B | $2.84B | — | — | $330.5M | $40.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACHC // BETA 1.07
FTRE // BETA 0.99